Clinical Trials Browser

Phase 2/3 × Prostatic Neoplasms × Ketorolac × Clear all

NCT05597878 2026-03-06

Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy

Phase 2/3 Suspended

Agnosia, Prostatic Neoplasms